CI · Cigna Group
United States · RS rating 82 · As of 2026-11-03
| Price | 295.44 USD |
|---|---|
| 1-day change | +0.1% |
| RS rating (overall / 1M / 3M / 12M) | 82 / 80 / 81 / 70 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 37 / 42 / 35 |
| Industry group (rank) | Medical-Managed Care (13) |
| EPS growth Q/Q | -33.5% |
| Sales growth Q/Q | +3.7% |
| Distance from 52-week high | +6.5% |
| Market cap (USD) | $73.8B |